Healthcare Industry News: Intuitive Surgical
News Release - January 3, 2012
VasoStitch Appoints David W. J. Smith as CEO"David Smith has extensive commercialization experience with new medical technologies and is very skilled at raising private equity for biomedical products," - Amir Belson, MD, VasoStitch Founder and Chairman
DANVILLE, Calif.--(Healthcare Sales & Marketing Network)-- VasoStitch, a start-up medical technology company, announced today the appointment of David W. J. Smith as President and Chief Executive Officer.
“David Smith has extensive commercialization experience with new medical technologies and is very skilled at raising private equity for biomedical products,” said Amir Belson, MD, Founder and Chairman of VasoStitch. Dr. Belson previously founded Neoguide Systems, a company that developed platform technology for minimally invasive surgical procedures and was acquired by Intuitive Surgical in 2009, and more recently has founded Emboline, Vascular Pathways and ZipLine Medical.
“VasoStitch has developed two platform technologies designed to access and close percutaneous therapy sites without the need for open surgery, thus likely to make catheter-based cardiac and vascular interventions simpler and more popular,” said David Smith. “I am very excited about helping make VasoStitch a great success.”
VasoStitch is an emerging medical device company that is developing nonsurgical transfemoral and transapical access-and-closure systems to facilitate deployment of large diameter transcatheter therapeutic devices—designed to reduce procedural complexity and eliminate need for an “open” surgical procedure.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.